Clinical characteristics and short-term recovery of hyposmia in hospitalized non-severe COVID-19 patients with Omicron variant in Shanghai, China

被引:6
作者
Shen, Jun [1 ]
Wu, Li [1 ]
Wang, Ping [1 ]
Shen, Xiaolei [1 ]
Jiang, Yuhan [1 ]
Liu, Jianren [1 ]
Chen, Wei [1 ]
机构
[1] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Sch Med, Dept Neurol, Shanghai, Peoples R China
关键词
COVID-19; Omicron; hyposmia; IL-6; recovery;
D O I
10.3389/fmed.2022.1038938
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundOlfactory dysfunction is a common neurological symptom of Corona Virus Disease 2019(COVID-19). Little is known about hyposmia after COVID-19 infection with Omicron variant in Chinese population. ObjectiveTo investigate the incidence, clinical characteristics and recovery of hyposmia in hospitalized non-severe COVID-19 patients with Omicron variant in Shanghai, China. MethodsThree hundred and forty-nine Chinese non-severe COVID-19 patients with Omicron variant were consecutively enrolled in a designated hospital to investigate the incidence of hyposmia in hospitalization and the recovery rate 1 month later. The visual assessment scale (VAS) was used to evaluate the severity of hyposmia. We compared the demographic, clinical features and treatment outcomes, as well as laboratory parameters between patients with and without hyposmia. ResultsThe cross-sectional survey showed that 22 (6.3%) hospitalized patients with non-severe COVID-19 had hyposmia. Patients with hyposmia were younger (61.5 vs. 72.0, p = 0.002), had more related clinical symptoms (sore throat, cough, poor appetite, diarrhea, myalgia and taste impairment, etc.), a higher proportion of moderate clinical type (31.8 vs. 13.5%, p = 0.028) and longer duration of hospitalization (11 vs. 8 days, p = 0.027) than those without hyposmia. Whereas, there were no significant differences regarding gender, comorbidity and nucleic acid conversion time between the two groups. Laboratory subgroup analyses demonstrated that patients with hyposmia had slightly low serum IL-6 and TNF-alpha levels. However, both of the levels were not associated with hyposmia occurrence in multivariate regression analyses. Further follow-up study disclosed that 16 of 22 (72.7%) hyposmia patients had recovered olfaction 1 month later. Serum IL-6 and TNF-alpha levels were similar between hyposmia recovered patients and those with persistent hyposmia. ConclusionAlthough the incidence of hyposmia after Omicron variant infection is relatively low and the short-term recovery rate is quite high, patients with hyposmia are prone to have a higher proportion of both upper and lower respiratory tract involvements, gastrointestinal and neurological symptoms, contributing to a longer duration of hospitalization.
引用
收藏
页数:9
相关论文
共 50 条
[41]   Dyspnea perception and neurological symptoms in non-severe COVID-19 patients [J].
Ora, Josuel ;
Liguori, Claudio ;
Puxeddu, Ermanno ;
Coppola, Angelo ;
Matino, Matteo ;
Pierantozzi, Mariangela ;
Mercuri, Nicola Biagio ;
Rogliani, Paola .
NEUROLOGICAL SCIENCES, 2020, 41 (10) :2671-2674
[42]   Home Management of COVID-19 Patients: A Successful Model in Non-severe COVID-19 Patients in the Developing World [J].
Alishan, Syed ;
Ali, Farheen ;
Iqbal, Zafar ;
Ammar, Ali ;
Muhammad, Atif S. ;
Farooq, Faiza ;
Mir, Ayaz ;
Salahuddin, Nawal ;
Saghir, Tahir ;
Karim, Musa .
CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (01)
[43]   Remdesivir treatment and clinical outcome in non-severe hospitalized COVID-19 patients: a propensity score matching multicenter Italian hospital experience [J].
Attena, Emilio ;
Caturano, Alfredo ;
Annunziata, Anna ;
Maraolo, Alberto Enrico ;
De Rosa, Annunziata ;
Fusco, Francesco Maria ;
Halasz, Geza ;
Dall'Ospedale, Valeria ;
Conte, Maddalena ;
Parisi, Valentina ;
Galiero, Raffaele ;
Sasso, Ferdinando Carlo ;
Fiorentino, Giuseppe ;
Russo, Vincenzo .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 79 (07) :967-974
[44]   Remdesivir treatment and clinical outcome in non-severe hospitalized COVID-19 patients: a propensity score matching multicenter Italian hospital experience [J].
Emilio Attena ;
Alfredo Caturano ;
Anna Annunziata ;
Alberto Enrico Maraolo ;
Annunziata De Rosa ;
Francesco Maria Fusco ;
Geza Halasz ;
Valeria Dall’Ospedale ;
Maddalena Conte ;
Valentina Parisi ;
Raffaele Galiero ;
Ferdinando Carlo Sasso ;
Giuseppe Fiorentino ;
Vincenzo Russo .
European Journal of Clinical Pharmacology, 2023, 79 :967-974
[45]   Topological data analysis of antibody dynamics of severe and non-severe patients with COVID-19 [J].
Blanco-Rodriguez, Rodolfo ;
Ordonez-Jimenez, Fernanda ;
Almocera, Alexis Erich S. ;
Chinney-Herrera, Gustavo ;
Hernandez-Vargas, Esteban .
MATHEMATICAL BIOSCIENCES, 2023, 361
[46]   Comparative analysis of laboratory indexes of severe and non-severe patients infected with COVID-19 [J].
Bao, Jinfeng ;
Li, Chenxi ;
Zhang, Kai ;
Kang, Haiquan ;
Chen, Wensen ;
Gu, Bing .
CLINICA CHIMICA ACTA, 2020, 509 :180-194
[47]   Characteristics of laboratory indexes in COVID-19 patients with non-severe symptoms in Hefei City, China: diagnostic value in organ injuries [J].
Tao Li ;
Lianzi Wang ;
Huihui Wang ;
Yufeng Gao ;
Xianwei Hu ;
Xuemei Li ;
Shubing Zhang ;
Yuanhong Xu ;
Wei Wei .
European Journal of Clinical Microbiology & Infectious Diseases, 2020, 39 :2447-2455
[48]   Characteristics of laboratory indexes in COVID-19 patients with non-severe symptoms in Hefei City, China: diagnostic value in organ injuries [J].
Li, Tao ;
Wang, Lianzi ;
Wang, Huihui ;
Gao, Yufeng ;
Hu, Xianwei ;
Li, Xuemei ;
Zhang, Shubing ;
Xu, Yuanhong ;
Wei, Wei .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2020, 39 (12) :2447-2455
[49]   Clinical characteristics of the delta variant of COVID-19 in Jingmen, China [J].
Bie, Fangfang ;
Yuan, Wensheng ;
Chen, Yafeng ;
Gao, Qijun .
MEDICINE, 2022, 101 (38) :E30812
[50]   Clinical Impact of Covid-19 Omicron Variant on Patients in Home Health Care [J].
Ando, Katsutoshi ;
Suzuki, Ayumi ;
Yoshida, Hiroki .
HOME HEALTH CARE MANAGEMENT AND PRACTICE, 2024, 36 (04) :326-333